Literature DB >> 27193259

Effectiveness and outcomes of a nurse practitioner-run chest pain evaluation unit.

Zahra Zhu1, Sirajul Islam1, Steven R Bergmann1,2,3.   

Abstract

BACKGROUND: Every year, more than 5 million patients seek medical care for chest pain.
OBJECTIVE: The goal of this study was to evaluate test utilization and outcomes of a nurse practitioner (NP)-based chest pain unit and compare results to data previously reported from our institution. DESIGN, SETTING, AND PARTICIPANTS: The records from 814 consecutive patients with chest pain admitted to the NP-run unit were compared to the outcomes of 250 patients admitted to a separate hospitalist-run unit at a New York City hospital.
RESULTS: Forty-four percent of patients in the NP unit underwent stress myocardial perfusion imaging (MPI) as the primary diagnostic test (compared to 22% in the hospitalist unit, p < .0001). The average length of stay was shorter for patients in the NP unit (2.7 ± 3.6 days compared to 3.9 ± 3.4 days, p < .0001). Additionally, the 90-day readmission rate was less for patients in the NP unit (2.7% vs. 3.9%, p < .0006).
CONCLUSIONS: An NP-run chest pain unit resulted in decreased length of stay and reduced readmission rates compared to a hospitalist-based unit. ©2016 American Association of Nurse Practitioners.

Entities:  

Keywords:  Nurse practitioner; chest pain; myocardial perfusion imaging; outcomes; telemetry

Mesh:

Year:  2016        PMID: 27193259     DOI: 10.1002/2327-6924.12377

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  2 in total

1.  A Preliminary Study on the Cultural Competence of Nurse Practitioners and Its Affecting Factors.

Authors:  Tsui-Ting Liu; Miao-Yen Chen; Yu-Mei Chang; Mei-Hsiang Lin
Journal:  Healthcare (Basel)       Date:  2022-04-03

2.  A novel inpatient PA staffing model for a community hospital.

Authors:  Danielle Bendicksen; Chaya Mangel Pflugeisen; Franchot van Slot
Journal:  JAAPA       Date:  2022-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.